Cyclophosphamide/Epirubicin/Prednisone/Rituximab/Vincristine Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of rituximab, cyclophosphamide, epirubicin, vincristine and prednisone that can be used to treat diffuse large B-cell lymphoma (DLBCL).

**Synonyms:** - Cyclophosphamide-Epirubicin-Prednisone-Rituximab-Vincristine - Cyclophosphamide-Epirubicin-Prednisone-Rituximab-Vincristine Regimen - Cyclophosphamide/Epirubicin/Prednisone/Rituximab/Vincristine - R-CEOP90 - R-CEOP90 (rituximab-abbs) - R-CEOP90 (rituximab-arrx) - R-CEOP90 (rituximab-blit) - R-CEOP90 (rituximab-pvvr) - R-CEOP90 (rituximab-rite) - R-CEOP90 (rituximab-rixa) - R-CEOP90 (rituximab-rixi) - R-CEOP90 Regimen - Rituximab-Cyclophosphamide-Epirubicin-Oncovin-Prednisone Regimen